Gene Query: RNASET2

Dataset Description Geneva Score
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 190.82
Transcriptome of diurnal human blood neutrophils 126.68
ARID1A regulates condensin II distribution and chromosomal partition 107.09
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 107.09
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 75.98
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 57.52
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 57.52
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 56.28
U2AF1 mutations alter splice site recognition in hematological malignancies 47.53
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 46.82
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 41.44
Single-nucleotide-resolution mapping of HBV promoters using CAGE 39.43
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 38.77
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 38.6
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 38.6
Transcriptional profiles of normal human mature B cells 37.19
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 35.86
Iron response of HepG2 cells 34.49
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 34.11
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 33.78
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 33.63
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 33.36
Transcriptome analysis of virus infected tissues 31.66
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 31.53
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 29.39
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 29.02
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 29.02
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 28.56
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 27.83
Transcriptomic analysis of human tonsillar TFH subsets 27.67
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 27.49
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 25.79
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 25.71
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 25.6
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 23.85
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 23.6
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 23.6
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 22.93
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 22.59
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 22.57
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 22.19
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 21.99
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 21.96
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 21.96
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 21.67
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 21.39
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 21.3
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 21.24
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 21.24
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 20.83
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 20.31
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 20.06
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 20.06
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 19.77
Transcriptional responses of human insulinoma cells to acute cytokine exposure 19.03
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 18.94
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 18.94
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 18.77
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 18.68
Human neutrophil genome during PMA- and E. coli encounter-induced activation 18.55
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 18.55
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 18.31
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 17.93
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 17.2
Primary Human B-cell Temporal Response to CD40L Stimulation 17.2
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 17.14
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 17.06
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 16.78
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 16.45
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 16.24
RNA-seq in HepG2 and IMR90 cells 15.98
Evolution of a transcriptional regulator from a transmembrane nucleoporin 15.98
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 15.73
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 15.73
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 15.67
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 15.44
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 15.37
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 15.27
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 15.18
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 15.07
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 14.84
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 14.77
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 14.57
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 14.56
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 14.41
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 14.38
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 14.36
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 14.23
RNA-seq of stable and unstable section of human atherosclerotic plaques 13.98
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 13.95
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 13.95
Genome-wide identification of cancer-specific alternative splicing in circRNA 13.94
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 13.81
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 13.78
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 13.74
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 13.74
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 13.72
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 13.72
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 13.68
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 13.68
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 13.55
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 13.54
Nonpregnant and term pregnant human myometrial tissues 13.4
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 13.4
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 13.28
CD86 regulates a pro-survival signal in myeloma cells 13.23
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 13.19
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 13.18
In situ CAPTURE of chromatin interactions by biotinylated dCas9 13.18
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 13.12
Tpl-2 and MEK small molecule inhibitors 13.08
Tpl-2 small molecule project 13.08
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 12.96
Global analysis of alternative splicing regulated by RBM10 12.87
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 12.81
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 12.75
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 12.74
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 12.74
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 12.7
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 12.57
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 12.57
WRN knockout effects upon gene expression in SW48 and OVK18 12.55
Stem and effector CD8 T-cells from human cancers 12.42
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 12.33
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.28
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 12.0
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 11.99
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 11.99
Short and Long RNA sequencing of human mature erythrocytes 11.95
Solid phase chemistry to covalently and reversibly capture thiolated RNA 11.95
MeRIP-seq for heat shock in B-cell lymphoma cells 11.74
Role of CD133 molecule in WNT response and renal repair 11.65
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 11.61
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 11.61
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 11.52
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 11.43
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 11.33
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 11.15
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 11.11
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 11.06
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 11.06
Microglia innatly develop within cerebral organoids 11.05
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 11.03
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 10.93
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 10.88
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 10.78
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 10.71
Total RNA sequencing of WT intestinal orgaonids. 10.69
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 10.69
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 10.58
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 10.42
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 10.42
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 10.41
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 10.32
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 10.3
mRNA expression profile of Lymphocytes by high-throuput sequencing 10.29
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 10.29
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 10.21
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 10.2
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 10.2
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 10.14
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 10.03
Human cells contain natural double-stranded RNAs with potential regulatory capacity 9.92
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 9.91
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 9.9
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 9.78
Generation and functional characterization of MDSC-like cells 9.78
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 9.78
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 9.78
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 9.74
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 9.72
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 9.64
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 9.51
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 9.5
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 9.5
RNA-seq of resting and activated CD4+ T cells +-JQ1 9.44
Efficient derivation of microglia-like cells from human pluripotent stem cells 9.38
Transcriptomes of human monocytes after ex vivo exposure to uric acid 9.37
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 9.37
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 9.37
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 9.29
The comparison of high-throughput single-cell RNA-seq methods 9.23
Targeted enhancer activation by a subunit of the integrator complex 9.17
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 9.12
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 9.1
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 9.09
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 9.05
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 8.98
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 8.87
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 8.87
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 8.84
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 8.79
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 8.76
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 8.73
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 8.73
NR2F2 study 8.69
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 8.69
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 8.66
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 8.65
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 8.62
RNA expression analysis upon JMJD1C depletion 8.62
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.47
BACH2 in human plasma cell fate decision 8.44
Transcriptome of activated human and mouse MAIT cells 8.39
Region-specific Innate Antiviral Responses of the Human Epididymis 8.34
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 8.31
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 8.3
Identification of renal resident macrophages across species 8.24
Be1 and Be2 B cells are transcriptionally distinct 8.15
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 8.1
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 8.1
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 8.05
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 8.05
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 8.05
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 8.04
MEIS1 regulates hematopoiesis in hPSCs 8.0
HNRNPM-regulated splicing dependencies in prostate cancer 7.99
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 7.99
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 7.97
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 7.95
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 7.94
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 7.89
Identification of global regulators of T-helper cell lineage specification 7.89
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 7.83
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 7.83
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 7.83
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 7.81
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 7.8
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 7.71
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 7.62
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 7.61
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 7.61
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 7.57
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 7.54
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 7.49
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 7.45
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 7.38
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 7.35
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 7.34
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 7.23
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 7.22
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 7.21
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 7.21
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 7.16
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 7.14
Transcriptome analysis of SKI knock-out in HL60 cells 7.14
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 7.11
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 7.07
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 7.07
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 7.02
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 6.97
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 6.94
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 6.92
PTHrP overexpression in MCF7 cells 6.91
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 6.78
Human embryonic stem cells in E8 and AKIT culture medium 6.78
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 6.62
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 6.61
Transcription control by the ENL YEATS domain in acute leukemia 6.56
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 6.56
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 6.45
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 6.4
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 6.4
Single-cell analysis of human kidney organoids 6.37
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 6.35
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 6.34
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 6.34
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 6.34
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 6.32
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 6.26
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 6.24
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.23
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.23
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 6.17
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 6.11
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 6.01
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 5.98
circNFIB suppresses lymphatic metastasis of pancreatic cancer 5.8
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 5.75
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 5.73
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 5.69
Spliceosomal disruption of the non-canonical BAF complex in cancer 5.62
Gene expression alterations of pancreatic intraepithlial neoplasia 5.58
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 5.57
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 5.54
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 5.54
ARID1A and ARID1B loss in HCT116 and TOV21G cells 5.49
Conservative alteration of chromosomal expression pattern across human solid tumor types 5.48
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 5.47
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 5.47
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 5.44
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 5.44
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 5.4
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 5.38
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 5.35
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 5.32
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.3
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 5.3
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 5.29
Identification of renal resident macrophages across species [C1] 5.25
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 5.23
Changes in human endometrial gland transcriptome over the window of implantation 5.15
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 5.07
The transcriptome of Kawasaki Disease arteritis 5.04
Trascriptome of thyroid cancer-induced macrophages 5.01
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 4.98
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 4.98
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 4.89
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 4.89
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 4.88
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.87
Human Treg NaCl stimulation 4.79
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.79
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 4.79
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 4.76
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 4.7
The Glioma-Infiltrating T Cell Receptor Repertoire 4.66
MARCKS and lnc-MARCKS act as inflammation regulators 4.65
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 4.62
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 4.6
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 4.6
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 4.55
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 4.55
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 4.55
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 4.49
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 4.47
Polarized B -cell functions 4.46
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 4.36
Widespread intronic polyadenylation diversifies immune cell transcriptomes 4.36
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 4.29
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 4.27
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 4.26
Loss of endometrial plasticity in recurrent pregnancy loss 4.26
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 4.25
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 4.11
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.09
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.03
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 4.02
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 3.98
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 3.95
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.89
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 3.88
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.87
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.87
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 3.85
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 3.78
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 3.75
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 3.74
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 3.74
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 3.72
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 3.54
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.38
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 3.25
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 3.24
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.22
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.2
Reprogrammed myeloid cell transcriptomes in NSCLC 3.19
Transcriptome of Stabilin-1 siRNA transfected human monocytes 3.18
Zika virus infection reprograms global transcription of host cells to allow sustained infection 3.16
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 3.12
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 3.12
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 3.1
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 3.1
RNA sequencing of human pancreatic cancer cell lines 3.07
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.06
CD74 role in transcription regulation [RNA-seq] 3.04
CD74 role in transcription regulation 3.04
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 3.03
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 3.02
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.98
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.89
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.89
The Genetic Landscape of Diamond-Blackfan Anemia 2.87
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 2.85
A novel target of EZH1/2 for treatment of mantle cell lymphoma 2.85
TAF1 is critical for AE driven leukemogenesis 2.81
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 2.81
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 2.81
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.65
Molecular analysis of renal cell carcinoma with unclassfied histology 2.63
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 2.63
Human Tfh cell RNA bulk sequencing 2.61
Expression profiling of MCF-7 cells with treatment of TCDD 2.6
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.6
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.59
Transcriptome analysis of peripheral blood monocytes 2.55
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 2.49
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 2.49
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 2.47
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 2.4
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.38
Transcriptomic analysis of human macrophages in 3D 2.3
Clinker: visualizing fusion genes detected in RNA-seq data 2.29
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 2.29
RNA-Seq of the corpus callosum from 12 individuals 2.26
The role of m6A/m-RNA methylation in stress response regulation 2.26
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 2.26
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.24
Hepatocyte maturation 2.24
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 2.21
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 2.17
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 2.17
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2.17
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 2.17
Gene profiling of human adult and pediatric liver cancer cells 2.15
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 2.12
Leucegene: ALL sequencing 2.07
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.02
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 1.98
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 1.96
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 1.96
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.96
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 1.88
Human optic chiasm from healthy controls and multiple sclerosis patients 1.86
Multiple sclerosis and EAE 1.86
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.84
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 1.82
An optimization system for isolating and sequencing of single human colon cancer cells 1.79
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 1.75
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.74
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.73
Expression patterns in chronic thromboembolic pulmonary hypertension 1.71
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.7
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.7
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 1.68
Measure transcript integrity using RNA-seq data 1.67
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.66
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 1.65
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.61
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.59
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.59
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 1.59
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.58
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.58
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.58
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.56
Transcriptomes in healthy and CHB fetal hearts 1.46
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 1.44
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.41
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.37
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.29
RNA sequencing of T-ALL (COG study) 1.26
Analyses of T-ALL (COG study) 1.26
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 1.25
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 1.25
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 1.24
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 1.21
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 1.21
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 1.21
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.19
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 1.17
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.12
Discovering human diabetes-risk gene function with genetics and physiological assays 1.11
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 1.1
Transcriptome analysis of CNS leukemia 1.1
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.09
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.02
Hepatic transcriptome of pediatric hepatoblastoma. 0.93
RNA seq analysis of human Fetal and adult derived Enterospheres 0.89
The pioneer factor CEBPA modulates vitamin D signaling 0.75
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.75
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 0.75
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.73
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.68
Effects of rFVIIIFc on human macrophages 0.62
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 0.59
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 0.59
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.58
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.57
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.5
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.5
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.41
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.41
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.37
Anti-inflammatory effect of indoleacrylic acid (IA) 0.34
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.32
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.32
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 0.31
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.31
Hepatosplenic T cell lymphoma 0.31
Total RNA-Seq data from leukemic patients with complex structural variants 0.28
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.25
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.22
RNA-seq of cancer cell lines treated with T-025 0.19
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.19
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.18
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.17
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.15
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.12
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 0.12
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.07
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.07
Gene expression of collecting duct carcinoma of the kidney 0.03
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.03
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.03
RNAseq of cell lines with knocked in ESR1 mutations 0.02
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.01
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.01
Preclinical model of obesity and ER-positive breast cancer 0.01
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation